Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors

(2010) Vanessa de Paula Soares et al.   BEHAVIOURAL BRAIN RESEARCH

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

(2010) José Alexandre S Crippa et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis

(2010) Celia JA Morgan et al.   NEUROPSYCHOPHARMACOLOGY

Further Study of the Psychometric Qualities of a Brief Screening Tool for Social Phobia (MINI-SPIN) Applied to Clinical and Nonclinical Samples

(2010) Flávia de Lima Osório et al.   PERSPECTIVES IN PSYCHIATRIC CARE

Diretrizes da Associação Médica Brasileira para o diagnóstico e diagnóstico diferencial do transtorno de ansiedade social

(2010) Marcos Hortes N. Chagas et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Uso terapêutico dos canabinoides em psiquiatria

(2010) José Alexandre S. Crippa et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Instituto Nacional de Ciência e Tecnologia em Medicina Translacional (INCT-TM): abordagens metodológicas

(2010) Jaime E. C. Hallak et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Social anxiety disorder: what are we losing with the current diagnostic criteria?

(2009) A. S. Filho et al.   ACTA PSYCHIATRICA SCANDINAVICA

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

(2009) Paolo Fusar-Poli et al.   ARCHIVES OF GENERAL PSYCHIATRY

Cannabis and anxiety: a critical review of the evidence

(2009) José Alexandre Crippa et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol

(2009) Paolo Fusar-Poli et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances

(2009) Y. Ren et al.   JOURNAL OF NEUROSCIENCE

Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition

(2008) Stefan J. Borgwardt et al.   BIOLOGICAL PSYCHIATRY

Grey matter correlates of cognitive measures of the simulated public speaking test in social anxiety spectrum: a voxel-based study

(2008) J.A. Crippa et al.   EUROPEAN PSYCHIATRY

Comparability Between Telephone and Face-to-Face Structured Clinical Interview forDSM-IVin Assessing Social Anxiety Disorder

(2008) José Alexandre S. Crippa et al.   PERSPECTIVES IN PSYCHIATRIC CARE

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

(2008) Alline Cristina Campos et al.   PSYCHOPHARMACOLOGY

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA

Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence

(2007) Julia D. Buckner et al.   JOURNAL OF PSYCHIATRIC RESEARCH